US Stock MarketDetailed Quotes

RVNC Revance Therapeutics

Watchlist
  • 3.780
  • -0.010-0.26%
Close Apr 19 16:00 ET
  • 3.880
  • +0.100+2.64%
Post 16:05 ET
393.94MMarket Cap-986P/E (TTM)

Revance Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Business Currency:USD
2023/FY
Stock NameRevenueRatio
Product Segment221.79M94.77%
Service Segment12.25M5.23%
Region Currency:USD
2023/FY
Stock NameRevenueRatio
United States234.04M100.00%

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg